- ImmunoGen (NASDAQ:IMGN) EVP, Technical Operations and Commercial Development Sandra Poole will resign at the end of the month to pursue other opportunities. VP, Technical Operations Thomas Ryll, Ph.D., will assume responsibility for manufacturing and supply chain operations.